Literature DB >> 19478680

Therapeutic effects of mucosal tolerance on experimental colitis in rats.

Zhang Shan-Shan1, Liu Yu-Lan.   

Abstract

OBJECTIVE: To analyze the therapeutic effect of oral tolerance and nasal tolerance singly and in combination with mucosal adjuvant on experimental colitis in rats.
METHODS: Rat models were established using trinitrobenzenesulphonic acid enemas. Ovalbumin was used as inducing antigen and lipopolysaccharide as adjuvant. Colonic scores, splenic mononuclear cell proliferation, and expressions of Toll-like receptors (TLR) and regulatory T cells were determined.
RESULTS: Colonic scores decreased most significantly after ovalbumin and lipopolysaccharide nasal administration (P<0.05). Colonic expression of forkhead box P3 in rats after ovalbumin and lipopolysaccharide oral (P<0.05) and nasal administration (P<0.01) were both significantly higher than untreated rats. TLR2 expression on CD4(+)CD25(+) T cells decreased most significantly after ovalbumin and lipopolysaccharide nasal therapies (P<0.01). TLR4 colonic expression decreased significantly after ovalbumin and lipopolysaccharide oral administration (P<0.05) and lipopolysaccharide oral administration (P<0.05).
CONCLUSION: Although experimental colitis prevented oral tolerance, nasal tolerance was successfully induced. The therapeutic effect of nasal tolerance combined with adjuvant produced the best results. TLR downregulation and CD4(+)CD25(+) T cells upregulation were involved in mucosal tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478680     DOI: 10.1097/MEG.0b013e32830edb29

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice.

Authors:  Richard Kellermayer; Scot E Dowd; R Alan Harris; Alfred Balasa; Tiffany D Schaible; Randy D Wolcott; Nina Tatevian; Reka Szigeti; Zhijie Li; James Versalovic; C Wayne Smith
Journal:  FASEB J       Date:  2011-01-12       Impact factor: 5.191

2.  Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice.

Authors:  David Dunkin; M Cecilia Berin; Lucie Mondoulet; Steven Tobar; Garabet Yeretssian; Leticia Tordesillas; Alina Iuga; Thibaut Larcher; Virginia Gillespie; Pierre-Henri Benhamou; Jean-Frederic Colombel; Hugh A Sampson
Journal:  Inflamm Bowel Dis       Date:  2017-11       Impact factor: 5.325

3.  Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice.

Authors:  Lisiery N Paiatto; Fernanda G D Silva; Julia Bier; Márcia R Brochetto-Braga; Áureo T Yamada; Wirla M S C Tamashiro; Patricia U Simioni
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.